STAT November 13, 2023
WASHINGTON – The American Medical Association called on insurance companies, employers, and government programs to cover obesity treatments even as many remain reluctant to pay for them, fearing the costs of covering the drugs at a mass scale.
The large physicians’ lobbying group voted to pass a resolution at the association’s interim meeting Monday saying it will “urge all payers to ensure coverage parity for evidence-based treatment of obesity, including FDA- approved medications without exclusions or additional carve-outs.”
Medicare is prohibited by law from covering weight loss treatments, and commercial coverage has historically been spotty, with many insurers viewing them as cosmetic rather than medical treatments. More recently, the emergence of GLP-1-based treatments like Novo Nordisk’s Wegovy and Eli Lilly’s...
Today's Sponsors
Today's Sponsor